Circulating cytokines reflect the expression of pro-inflammatory cytokines in atherosclerotic plaques

Atherosclerosis

Volumn 241, Issue 2, 2015, Pages 443-449

  Edsfeldt, Andreas ^a,b   Grufman, Helena ^a   Asciutto, Giuseppe ^b   Nitulescu, Mihaela ^a   Persson, Ana ^a,b   Nilsson, Marie ^a,b   Nilsson, Jan ^a   Gonçalves, Isabel ^a,b  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Atherosclerosis; Biomarker; Cytokines; Inflammation

Indexed keywords

ALPHA ACTIN; CD40 LIGAND; CYTOKINE; FRACTALKINE; GAMMA INTERFERON; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR AB; RANTES; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

AGED; ARTICLE; CAROTID ATHEROSCLEROSIS; CAROTID ENDARTERECTOMY; CONTROLLED STUDY; DISEASE ASSOCIATION; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TRANSIENT ISCHEMIC ATTACK; VASCULAR SMOOTH MUSCLE CELL; ATHEROSCLEROSIS; BLOOD; BRAIN CIRCULATION; INFLAMMATION; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; PLAQUE, ATHEROSCLEROTIC; SENSITIVITY AND SPECIFICITY; SWEDEN;

AGED; ATHEROSCLEROSIS; CEREBROVASCULAR CIRCULATION; CHEMOKINE CCL4; CHEMOKINE CX3CL1; CYTOKINES; ENDARTERECTOMY, CAROTID; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION; INTERFERON-GAMMA; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PLAQUE, ATHEROSCLEROTIC; SENSITIVITY AND SPECIFICITY; SWEDEN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84936803620     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2015.05.019     Document Type: Article

References (34)

1. Falk E. Plaque rupture with severe pre-existing stenosis precipitating coronary thrombosis. Characteristics of coronary atherosclerotic plaques underlying fatal occlusive thrombi. Br. Heart J. 1983, 50:127-134.
2. el Fawal M.A., Berg G.A., Wheatley D.J., Harland W.A. Sudden coronary death in Glasgow: nature and frequency of acute coronary lesions. Br. Heart J. 1987, 57:329-335.
3. Amento E.P., Ehsani N., Palmer H., Libby P. Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells. Arterioscler. Thromb. 1991, 11:1223-1230.
4. Saren P., Welgus H.G., Kovanen P.T. TNF-alpha and IL-1beta selectively induce expression of 92-kda gelatinase by human macrophages. J. Immunol. 1996, 157:4159-4165.
5. Shah P.K., Falk E., Badimon J.J., Fernandez-Ortiz A., Mailhac A., Villareal-Levy G., Fallon J.T., Regnstrom J., Fuster V. Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture. Circulation 1995, 92:1565-1569.
6. van der Wal A.C., Becker A.E., van der Loos C.M., Das P.K. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 1994, 89:36-44.
7. Finn A.V., Nakano M., Narula J., Kolodgie F.D., Virmani R. Concept of vulnerable/unstable plaque. Arterioscler. Thromb. Vasc. Biol. 2010, 30:1282-1292.
8. Sano K., Kawasaki M., Ishihara Y., Okubo M., Tsuchiya K., Nishigaki K., Zhou X., Minatoguchi S., Fujita H., Fujiwara H. Assessment of vulnerable plaques causing acute coronary syndrome using integrated backscatter intravascular ultrasound. J. Am. Coll. Cardiol. 2006, 47:734-741.
9. Toussaint J.F., LaMuraglia G.M., Southern J.F., Fuster V., Kantor H.L. Magnetic resonance images lipid, fibrous, calcified, hemorrhagic, and thrombotic components of human atherosclerosis in vivo. Circulation 1996, 94:932-938.
10. Wassélius J.A., Larsson S.A., Jacobsson H. Fdg-accumulating atherosclerotic plaques identified with 18f-fdg-pet/ct in 141 patients. Mol. Imaging Biol. 2009, 11:455-459.
11. Ballantyne C.M., Hoogeveen R.C., Bang H., Coresh J., Folsom A.R., Heiss G., Sharrett A. Lipoprotein-associated phospholipase a2, high-sensitivity c-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the atherosclerosis risk in communities (Aric) study. Circulation 2004, 109:837-842.
12. Blackburn R., Giral P., Bruckert E., André J.M., Gonbert S., Bernard M., Chapman M.J., Turpin G. Elevated c-reactive protein constitutes an independent predictor of advanced carotid plaques in dyslipidemic subjects. Arterioscler. Thromb. Vasc. Biol. 2001, 21:1962-1968.
13. Ridker P., Cushman M., Stampfer M., Tracy R., Hennekens C. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N. Engl. J. Med. 1997, 336:973-979.
14. Grufman H., Gonçalves I., Edsfeldt A., Nitulescu M., Persson A., Nilsson M., Nilsson J. Plasma levels of high-sensitive c-reactive protein do not correlate with inflammatory activity in carotid atherosclerotic plaques. J. Intern Med. 2014, 275:127-133.
15. Libby P., Ridker P.M., Maseri A. Inflammation and atherosclerosis. Circulation 2002, 105:1135-1143.
16. Goncalves I., Moses J., Dias N., Pedro L.M., Fernandes e Fernandes J., Nilsson J., Ares M.P. Changes related to age and cerebrovascular symptoms in the extracellular matrix of human carotid plaques. Stroke 2003, 3:616-622.
17. Ludvigsson J.F., Andersson E., Ekbom A., Feychting M., Kim J.L., Reuterwall C., Heurgren M., Olausson P.O. External review and validation of the Swedish national inpatient register. BMC Public Health 2011, 11:450.
18. Dutta P., Courties G., Wei Y., Leuschner F., Gorbatov R., Robbins C.S., Iwamoto Y., Thompson B., Carlson A.L., Heidt T., Majmudar M.D., Lasitschka F., Etzrodt M., Waterman P., Waring M.T., Chicoine A.T., van der Laan A.M., Niessen H.W., Piek J.J., Rubin B.B., Butany J., Stone J.R., Katus H.A., Murphy S.A., Morrow D.A., Sabatine M.S., Vinegoni C., Moskowitz M.A., Pittet M.J., Libby P., Lin C.P., Swirski F.K., Weissleder R., Nahrendorf M. Myocardial infarction accelerates atherosclerosis. Nature 2012, 487:325-329.
19. Massa M., Rosti V., Ferrario M., Campanelli R., Ramajoli I., Rosso R., De Ferrari G.M., Ferlini M., Goffredo L., Bertoletti A., Klersy C., Pecci A., Moratti R., Tavazzi L. Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction. Blood 2005, 105:199-206.
20. Peeters W., Hellings W.E., de Kleijn D.P., de Vries J.P., Moll F.L., Vink A., Pasterkamp G. Carotid atherosclerotic plaques stabilize after stroke: insights into the natural process of atherosclerotic plaque stabilization. Arterioscler. Thromb. Vasc. Biol. 2009, 29:128-133.
21. Malaud E., Merle D., Piquer D., Molina L., Salvetat N., Rubrecht L., Dupaty E., Galea P., Cobo S., Blanc A., Saussine M., Marty-Ané C., Albat B., Meilhac O., Rieunier F., Pouzet A., Molina F., Laune D., Fareh J. Local carotid atherosclerotic plaque proteins for the identification of circulating biomarkers in coronary patients. Atherosclerosis 2014, 233:551-558.
22. Reape T.J., Groot P.H. Chemokines and atherosclerosis. Atherosclerosis 1999, 147:213-225.
23. Tedgui A., Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol. Rev. 2006, 86:515-581.
24. Xu F., Lv S., Chen Y., Song X., Jin Z., Yuan F., Zhou Y., Li H. Macrophage inflammatory protein-1β and fibrinogen are synergistic predictive markers of prognosis of intermediate coronary artery lesions. Cardiology 2012, 121:12-19.
25. Ridker P.M., Rifai N., Pfeffer M., Sacks F., Lepage S., Braunwald E. Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation 2000, 101:2149-2153.
26. Skoog T., Dichtl W., Boquist S., Karpe F., Tang R., Bond M.G., de Faire U., Nilsson J., Eriksson P., Hamsten A. Plasma tumour necrosis factor-alpha and early carotid atherosclerosis in healthy middle-aged men. Eur. Heart J. 2002, 23:376-383.
27. Greaves D.R., Häkkinen T., Lucas A.D., Liddiard K., Jones E., Quinn C.M., Senaratne J., Green F.R., Tyson K., Boyle J., Shanahan C., Weissberg P.L., Gordon S., Ylä-Hertualla S. Linked chromosome 16q13 chemokines, macrophage-derived chemokine, fractalkine, and thymus and activation-regulated chemokine, are expressed in human atherosclerotic lesions. Arterioscler. Thromb. Vasc. Biol. 2001, 21:923-929.
28. Lucas A.D., Bursill C., Guzik T.J., Sadowski J., Channon K.M., Greaves D.R. Smooth muscle cells in human atherosclerotic plaques express the fractalkine receptor cx3cr1 and undergo chemotaxis to the cx3c chemokine fractalkine (cx3cl1). Circulation 2003, 108:2498-2504.
29. Damås J.K., Boullier A., Waehre T., Smith C., Sandberg W.J., Green S., Aukrust P., Quehenberger O. Expression of fractalkine (cx3cl1) and its receptor, cx3cr1, is elevated in coronary artery disease and is reduced during statin therapy. Arterioscler. Thromb. Vasc. Biol. 2005, 25:2567-2572.
30. Ikejima H., Imanishi T., Tsujioka H., Kashiwagi M., Kuroi A., Tanimoto T., Kitabata H., Ishibashi K., Komukai K., Takeshita T., Akasaka T. Upregulation of fractalkine and its receptor, cx3cr1, is associated with coronary plaque rupture in patients with unstable angina pectoris. Circ. J. 2010, 74:337-345.
31. Bergström I., Backteman K., Lundberg A., Ernerudh J., Jonasson L. Persistent accumulation of interferon-γ-producing cd8+cd56+ t cells in blood from patients with coronary artery disease. Atherosclerosis 2012, 224:515-520.
32. Methe H., Brunner S., Wiegand D., Nabauer M., Koglin J., Edelman E.R. Enhanced t-helper-1 lymphocyte activation patterns in acute coronary syndromes. J. Am. Coll. Cardiol. 2005, 45:1939-1945.
33. Jha H.C., Divya A., Prasad J., Mittal A. Plasma circulatory markers in male and female patients with coronary artery disease. Heart Lung 2010, 39:296-303.
34. Fagerberg B., Ryndel M., Kjelldahl J., Akyürek L.M., Rosengren L., Karlström L., Bergström G., Olson F.J. Differences in lesion severity and cellular composition between in vivo assessed upstream and downstream sides of human symptomatic carotid atherosclerotic plaques. J. Vasc. Res. 2010, 47:221-230.